Post-Transplantation Cyclophosphamide: An Old Nemesis to a New Transplant Paradigm?

JACC CardioOncol. 2021 Jun 15;3(2):260-262. doi: 10.1016/j.jaccao.2021.04.004. eCollection 2021 Jun.

Authors

Seth J Rotz^{1

2}, Patrick Collier³, Betty K Hamilton²

Affiliations

¹ Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Pediatric Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
² Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
³ Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

No abstract available

Keywords: PT-Cy; cardiomyopathy; cardiotoxicity; cyclophosphamide; heart failure; hematopoietic cell transplantation.

Publication types

Editorial